Literature DB >> 11488065

Immunophenotyping large B-cell lymphomas. Flow cytometric pitfalls and pathologic correlation.

H C Bertram1, I J Check, M A Milano.   

Abstract

Large cell lymphomas often challenge the diagnostic flow cytometrist. The purposes of this study were to improve our protocols for diagnosing large cell lymphomas and to correlate flow cytometric (FC) data with demographic and histologic features. We identified 63 cases of large B-cell lymphoma between January 1, 1995, and July 30, 1999, and reviewed the diagnostic slides and FC light scatter and staining patterns. The 51 lymphomas with adequate material for systemic review fell into 2 light scatter patterns: "clear cut," with large abnormal cells (high forward scatter relative to normal lymphocytes), 17 cases (33%); and "complex," 34 cases (67%). Clear-cut cases were more mitotically active (average of 42 vs 25 per 10 high-power fields), with higher cellularity. Apoptosis, geographic necrosis, and sclerosis were present histologically in many cases, regardless of FC findings. We conclude that morphologic features of large cell lymphomas do not predict which cases will be difficult to diagnose by FC. Gating strategies can be critical to improve the diagnostic yield.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488065     DOI: 10.1309/BA3U-RMTU-D7UJ-M8DR

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Primary esophageal lymphoma: case series and review of the literature.

Authors:  Krishdeep Singh Chadha; Francisco J Hernandez-Ilizaliturri; Milind Javle
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  AIRR Community Guide to Planning and Performing AIRR-Seq Experiments.

Authors:  Anne Eugster; Magnolia L Bostick; Nidhi Gupta; Encarnita Mariotti-Ferrandiz; Gloria Kraus; Wenzhao Meng; Cinque Soto; Johannes Trück; Ulrik Stervbo; Eline T Luning Prak
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms.

Authors:  Wasif Riaz; Francisco J Hernandez-Ilizaliturri; Myron S Czuczman
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

5.  Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls.

Authors:  Iole Cordone; Serena Masi; Mariantonia Carosi; Antonello Vidiri; Francesco Marchesi; Mirella Marino; Stefano Telera; Alessia Pasquale; Andrea Mengarelli; Laura Conti; Edoardo Pescarmona; Andrea Pace; Carmine M Carapella
Journal:  J Exp Clin Cancer Res       Date:  2016-08-27

6.  The Diagnosis of Gastric Mucosa-associated Lymphoid Tissue Lymphoma by Flow Cytometry and Fluorescence in situ Hybridization of Biopsy Specimens.

Authors:  Katsunori Matsueda; Sizuma Omote; Masahiro Sakata; Isao Fujita; Jouichiro Horii; Tatsuya Toyokawa
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

7.  Fine needle aspiration cytology in the evaluation of lymphoid lesions: a retrospective study of the utility of flow cytometry in conjunction with morphology.

Authors:  Emad M Said Raddaoui; Lubna Sayage-Rabie; Robert S Beissner
Journal:  Ann Saudi Med       Date:  2012 Mar-Apr       Impact factor: 1.526

8.  Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility.

Authors:  Jeffrey W Craig; Michael J Mina; Jennifer L Crombie; Ann S LaCasce; David M Weinstock; Geraldine S Pinkus; Olga Pozdnyakova
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

9.  Clinicopathological analysis of diffuse large B-cell lymphoma lacking surface immunoglobulin light chain restriction on flow cytometry.

Authors:  Yosuke Nakaya; Miho Sakaida; Masahiro Yoshida; Katsujun Shimizu; Naoko Yagi; Minako Tsutsumi; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Takeshi Inoue; Takahisa Yamane
Journal:  J Clin Exp Hematop       Date:  2021-10-26

10.  Flow cytometric immunophenotyping (FCI) of lymphoma: correlation with histopathology and immunohistochemistry.

Authors:  Abeer M El-Sayed; Mohammad H El-Borai; Abeer A Bahnassy; Shadia M S El-Gerzawi
Journal:  Diagn Pathol       Date:  2008-11-06       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.